Drugs / oglufanide
oglufanide
also known as
Glufanide disodium · IM862 · NSC-334073 · Oglufanida · oglufanide disodium · Oglufanide sodium
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00003773 | Feb 1999 → Jul 2000 | ovarian cancer | University of Southern California | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT00017303 | Jan 2001 → ? | ovarian cancer, primary peritoneal carcinoma | Cytran | Unknown | No outcome recorded |
| Phase 2 | NCT00006037 | Nov 1999 → Nov 2001 | colorectal cancer | University of Southern California | Terminated | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00002445 | — | HIV infectious disease, Kaposi's sarcoma | Cytran | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | oglufanide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00006037 ↗ |
| Known as | Glufanide disodium | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111029 ↗ |
| Known as | IM862 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002445 ↗ |
| Known as | NSC-334073 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111029 ↗ |
| Known as | Oglufanida | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111029 ↗ |
| Known as | oglufanide disodium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00017303 ↗ |
| Known as | Oglufanide sodium | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111029 ↗ |
| Modality | Small molecule | — CHEMBL2111029 ↗ |
| Route | Intranasal | “given intranasally every other day” NCT00002445 ↗ |